[Urotractin in the treatment of an infection of the kidneys, urinary tract and prostate].
Clinical and bacteriological effects of urotractin are analysed for 60 patients with infectious-inflammatory diseases of the kidney, urinary tracts and prostate treated in 3 urological clinics of Moscow. The drug was given 10 days in a dose 400 mg twice a day. Urotractin demonstrated high efficacy against both gram-negative and gram-positive bacteria. The results were the same in in- and outpatients.
Lopatkin
N A
NA
Trapeznikova
M F
MF
Mazo
E B
EB
Derevianko
I I
II
Sobolevskiĭ
A B
AB
Dolzhenok
A N
AN
Meshkov
V V
VV
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000892:Anti-Infective Agents, Urinary / Q000008:administration & dosage*; D002908:Chronic Disease; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D009393:Nephritis / Q000188:drug therapy*; D010876:Pipemidic Acid / Q000008:administration & dosage*; D011472:Prostatitis / Q000188:drug therapy*; D013997:Time Factors; D014552:Urinary Tract Infections / Q000188:drug therapy*
D000892:Anti-Infective Agents, Urinary; D010876:Pipemidic Acid